Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Rhea-AI Summary

Carlsmed (Nasdaq: CARL) said CEO and Chairman Mike Cordonnier will present at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans. A live webcast is available to registered participants and a replay will be posted afterward.

News Market Reaction – CARL

+0.08%

3 alerts

+0.08% News Effect

+$263K Valuation Impact

$329M Market Cap

1.4x Rel. Volume

On the day this news was published, CARL gained 0.08%, reflecting a mild positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $263K to the company's valuation, bringing the market cap to $329M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 2, 2026 Presentation time: 11:30 AM CST

2 metrics

Conference date March 2, 2026 Canaccord Genuity Musculoskeletal Conference presentation

Presentation time 11:30 AM CST Scheduled slot at 2026 Canaccord Genuity Musculoskeletal Conference

Market Reality Check

Price: $11.70 Vol: Volume 117,055 is 1.46x t...

normal vol

$11.70 Last Close

Volume Volume 117,055 is 1.46x the 20-day average of 80,376, indicating elevated interest ahead of the conference. normal

Technical Shares at 12.77 are trading below the 200-day MA of 13.23 and about 25.71% under the 52-week high.

Peers on Argus

CARL gained 2.08% with mixed peer moves: NRC up 2.32%, TALK up 2.89%, OPRX down ...

1 Down

CARL gained 2.08% with mixed peer moves: NRC up 2.32%, TALK up 2.89%, OPRX down 3.76%, and others flat to slightly positive, suggesting stock-specific factors rather than a broad sector move.

Historical Context

5 past events · Latest: Feb 18 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 18	New procedure milestone	Positive	+6.0%	First personalized corra cervical plating procedure ahead of commercial launch.
Feb 11	Earnings date notice	Neutral	-5.8%	Announcement of upcoming Q4 and full-year 2025 results call date.
Feb 10	New procedure milestone	Positive	-0.1%	First aprevo lumbar bi-lateral posterior fusion procedure at major hospital.
Jan 12	Preliminary revenue update	Positive	+13.8%	Strong preliminary Q4 and 2025 revenue growth versus prior year levels.
Jan 06	Clinical data publication	Positive	+2.9%	Peer-reviewed 2-year data showing reduced revision rates with aprevo implants.

Pattern Detected

Positive clinical and revenue updates have often coincided with favorable price reactions, while more neutral scheduling news has sometimes seen weakness.

Recent Company History

Over the past few months, Carlsmed has reported several operational and clinical milestones. Preliminary Q4 and 2025 revenue on Jan 12, 2026 drove a 13.79% gain, and positive lumbar 2‑year data on Jan 6, 2026 saw a 2.94% rise. New procedure announcements on Feb 10 and Feb 18, 2026 produced mixed reactions, including a 5.99% increase and a small decline. An earnings date notice on Feb 11, 2026 coincided with a -5.78% move. Today’s conference participation fits the pattern of non-fundamental news amid a busy update cycle.

Market Pulse Summary

This announcement highlights Carlsmed’s participation in the 2026 Canaccord Genuity Musculoskeletal ...

Analysis

This announcement highlights Carlsmed’s participation in the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST, providing additional visibility to investors and clinicians via a live webcast and replay. It follows recent milestones, including strong preliminary 2025 revenue and first-in-procedure updates. Investors may watch upcoming formal 2025 results, further clinical data, and commercialization milestones to better assess how conference messaging aligns with the company’s execution and growth trajectory.

Key Terms

musculoskeletal

1 terms

musculoskeletal medical

"2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM"

Musculoskeletal relates to the system of bones, muscles, joints, and tissues that support and move the body. It is important to investors because issues or changes in this system can impact the health and productivity of individuals, potentially affecting industries such as healthcare, pharmaceuticals, and insurance. Understanding musculoskeletal health helps gauge broader trends in healthcare spending and workforce well-being.

AI-generated analysis. Not financial advice.

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com

FAQ

When will Carlsmed (CARL) present at the 2026 Canaccord Genuity Musculoskeletal Conference?

Carlsmed will present on March 2, 2026 at 11:30 AM CST. According to Carlsmed, CEO Mike Cordonnier is scheduled to speak in New Orleans with a live webcast option for registered attendees and a replay posted after the presentation.

How can investors watch Carlsmed's (CARL) presentation on March 2, 2026?

Investors can view a live webcast with registration. According to Carlsmed, a live webcast will be available to registered participants and a replay will be posted afterward at the provided webcast URL for on-demand viewing.

Who will represent Carlsmed (CARL) at the Canaccord Musculoskeletal Conference 2026?

Mike Cordonnier, Carlsmed's CEO and Chairman, will present at the event. According to Carlsmed, Cordonnier will deliver the company presentation on March 2, 2026, offering an executive update to attendees and webcast viewers.

Where is the 2026 Canaccord Genuity Musculoskeletal Conference presentation by CARL being held?

The presentation will take place in New Orleans, Louisiana. According to Carlsmed, the company’s session is scheduled at the conference venue on March 2, 2026 at 11:30 AM CST with online access via webcast.

Will a replay of Carlsmed's (CARL) March 2, 2026 presentation be available online?

Yes, a replay will be posted for later viewing at the webcast link. According to Carlsmed, the webcast replay will be available after the live presentation at the event’s provided URL for registered and subsequent viewers.